COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,556 Articles (22,400 medRxiv, 8,156 bioRxiv)

Most recent first Previous |  Page 1176: Articles 11751-11760  | Next

Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy
Choudhary, M. C., Chew, K. W., Deo, R., Flynn, J. P., Regan, J., Crain, C. R., Moser, C., Hughes, M., Ritz, J., Ribeiro, R. M., Ke, R., Dragavon, J. A., Javan, A. C., Nirula, A., Klekotka, P., Greninger, A. L., Fletcher, C. V., Daar, E. S., Wohl, D. A., Eron, J. J., Currier, J. S., Parikh, U. M., Sieg, S. F., Perelson, A. S., Coombs, R. W., Smith, D. M., Li, J. Z.
10.1101/2021.09.03.21263105 — Posted: 2021-09-15
Y380Q novel mutation in receptor-binding domain of SARS-CoV-2 spike protein together with C379W interfere in the neutralizing antibodies interaction
Sartor, I. T. S., Varela, F. H., Meireles, M. R., Kern, L. B., Azevedo, T. R., Giannini, G. L. T., da Silva, M. S., Demoliner, M., Gularte, J. S., de Almeida, P. R., Fleck, J. D., Zavaglia, G. O., Fernandes, I. R., de David, C. N., Santos, A. P., de Almeida, W. A. F., Porto, V. B. G., Scotta, M. C., Spilki, F. R., Vieira, G. F., Stein, R. T., Polese-Bonatto, M.
10.1101/2021.09.10.21262695 — Posted: 2021-09-14
A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia
Sanchez, C. A., Li, H., Phelps, K. L., Zambrana-Torrelio, C., Wang, L.-F., Olival, K. J., Daszak, P.
10.1101/2021.09.09.21263359 — Posted: 2021-09-14 Discussion: Onsite
Low dose hydroxychloroquine prophylaxis for COVID-19 - a prospective study
RE-HCP2 study group, , Panda, P. K.
10.1101/2021.09.13.21262971 — Posted: 2021-09-14
Development of a novel, pan-variant aerosol intervention for COVID-19
Shoemaker, R. H., Panettieri, R. A., Libutti, S. K., Hochster, H. S., Watts, N. R., Wingfield, P. T., Starkl, P. M., Pimenov, L., Gawish, R., Hladik, A., Knapp, S., Boring, D., White, J. M., Lawrence, Q., Boone, J., Marshall, J. D., Matthews, R. L., Cholewa, B. D., Richig, J. W., Chen, B. T., McCormick, D. L., Gugensberger, R., Holler, S., Penninger, J. M., Wirnsberger, G.
10.1101/2021.09.14.459961 — Posted: 2021-09-14
SARS-CoV-2 infection fatality rates in India: systematic review, meta-analysis and model-based estimation
Zimmermann, L., Bhattacharya, S., Purkayastha, S., Kundu, R., Bhaduri, R., Ghosh, P., Mukherjee, B.
10.1101/2021.09.08.21263296 — Posted: 2021-09-14
Mitoxantrone dihydrochloride, an FDA approved drug, binds with SARS-CoV-2 NSP1 C-terminal
Kumar, P., Bhardwaj, T., Giri, R.
10.1101/2021.09.14.460211 — Posted: 2021-09-14
Prolific Induction of IL-6 in Human Cells by SARS-CoV-2-derived Peptide is Attenuated by Recombinant Human Anti-inflammatory Cytokines made in planta.
Anborgh, P. H., Kolotilin, I., Owens, N., Mahboob, A. A.
10.1101/2021.09.14.460246 — Posted: 2021-09-14
Effect of ORF7 of SARS-CoV-2 on the chemotaxis of monocytes and neutrophils in vitro
Wang, G., Guan, J., Li, G., Wu, F., Yang, Q., Huang, C., Shao, J., Xu, L., Guo, Z., Zhou, Q., Zhu, H., Chen, Z.
10.1101/2021.09.13.460185 — Posted: 2021-09-14
Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques
Yu, J., Collins, N., Mercado, N. B., McMahan, K., Chandrashekar, A., Liu, J., Anioke, T., Chang, A., Giffin, V., Hope, D., Sellers, D., Nampanya, F., Gardner, S., Barrett, J., Wan, H., Velasco, J., Teow, E., Cook, A., Van Ry, A., Pessaint, L., Andersen, H., Lewis, M., Hofer, C., Burke, D. S., Barkei, E., King, H., Subra, C., Bolton, D. L., Modjarrad, K., Michael, N., Barouch, D. H.
10.1101/2021.09.13.460191 — Posted: 2021-09-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).